Literature DB >> 1711289

Cytokeratin expression and vimentin content in large cell anaplastic lymphomas and other non-Hodgkin's lymphomas.

C Gustmann1, M Altmannsberger, M Osborn, H Griesser, A C Feller.   

Abstract

The immunophenotypes of 74 malignant lymphomas (9 Hodgkin's disease, 19 low-grade B-cell, 20 high-grade B-cell, 8 T-cell, and 18 large cell anaplastic lymphomas [LCAL]) have been characterized with antibodies against leucocyte differentiation antigens, keratin, and vimentin. All the non-LCAL were CD45 positive and keratin negative. The LCALs had a more varied immunophenotype, with CD45 present only in 11 of 18 cases and keratin present in 5 of 18 of these rare lymphomas. The lymphoid origin of these latter cases was proven by gene rearrangement studies. All LCALs were CD30+, and, where tested, vimentin positive. Of four different vimentin monoclonal antibodies tested, V9 and MVI stained the highest number of lymphomas. Positive staining of tumor cells was seen in 61 of 71 cases. Vimentin-negative cases included Burkitt's as well as some follicular lymphomas.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711289      PMCID: PMC1886410     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  40 in total

1.  Coexpression of epithelial membrane antigen (EMA), Ki-1, and interleukin-2 receptor by anaplastic large cell lymphomas. Diagnostic value in so-called malignant histiocytosis.

Authors:  G Delsol; T Al Saati; K C Gatter; J Gerdes; R Schwarting; P Caveriviere; F Rigal-Huguet; A Robert; H Stein; D Y Mason
Journal:  Am J Pathol       Date:  1988-01       Impact factor: 4.307

2.  Hodgkin and Reed-Sternberg cell associated monoclonal antibodies HRS-1 and HRS-2 react with activated cells of lymphoid and monocytoid origin.

Authors:  M Pfreundschuh; E Mommertz; M Meissner; A C Feller; R Hassa; G R Krueger; V Diehl
Journal:  Anticancer Res       Date:  1988 Mar-Apr       Impact factor: 2.480

3.  Structure of the human immunoglobulin mu locus: characterization of embryonic and rearranged J and D genes.

Authors:  J V Ravetch; U Siebenlist; S Korsmeyer; T Waldmann; P Leder
Journal:  Cell       Date:  1981-12       Impact factor: 41.582

4.  Updated Kiel classification for lymphomas.

Authors:  A G Stansfeld; J Diebold; H Noel; Y Kapanci; F Rilke; G Kelényi; C Sundstrom; K Lennert; J A van Unnik; O Mioduszewska
Journal:  Lancet       Date:  1988-02-06       Impact factor: 79.321

5.  Clinical importance of analysing malignant tumours of uncertain origin with immunohistological techniques.

Authors:  K C Gatter; C Alcock; A Heryet; D Y Mason
Journal:  Lancet       Date:  1985-06-08       Impact factor: 79.321

6.  Use of monoclonal antibodies for analyzing the distribution of the intermediate filament protein vimentin in human non-Hodgkin's lymphomas.

Authors:  R Giorno; C G Sciotto
Journal:  Am J Pathol       Date:  1985-09       Impact factor: 4.307

7.  Immunoreactivity for cytokeratin and epithelial membrane antigen in leiomyosarcoma.

Authors:  M Miettinen
Journal:  Arch Pathol Lab Med       Date:  1988-06       Impact factor: 5.534

8.  Leukocyte-common antigen and vimentin are reliable adjuncts in the diagnosis of non-Hodgkin's lymphoma in fine needle aspirates.

Authors:  W Domagala; J Lasota; M Chosia; K Weber; M Osborn
Journal:  Anal Quant Cytol Histol       Date:  1989-02       Impact factor: 0.302

9.  IgD myeloma/immunoblastic lymphoma cells expressing cytokeratin.

Authors:  H F Sewell; W D Thompson; D J King
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

10.  Vimentin gene: expression in human lymphocytes and in Burkitt's lymphoma cells.

Authors:  A Lilienbaum; V Legagneux; M M Portier; K Dellagi; D Paulin
Journal:  EMBO J       Date:  1986-11       Impact factor: 11.598

View more
  20 in total

Review 1.  Vimentin in cancer and its potential as a molecular target for cancer therapy.

Authors:  Arun Satelli; Shulin Li
Journal:  Cell Mol Life Sci       Date:  2011-06-03       Impact factor: 9.261

2.  Paraffin section immunohistochemistry in the diagnosis of Hodgkin's disease and anaplastic large cell (CD30+) lymphomas.

Authors:  A Carbone; A Gloghini; R Volpe
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Common acute lymphoblastic leukaemia-lymphoma expressing cytokeratin: a case report.

Authors:  F Menestrina; M Lestani; A Scarpa; G Viale; F Bonetti; G Pizzolo; M Chilosi
Journal:  Virchows Arch       Date:  1994       Impact factor: 4.064

4.  Single somatic ras gene point mutation in soft tissue malignant fibrous histiocytomas.

Authors:  R M Bohle; S Brettreich; R Repp; A Borkhardt; H Kosmehl; H M Altmannsberger
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

5.  TGF beta and bFGF synthesis and localization in Dupuytren's disease (nodular palmar fibromatosis) relative to cellular activity, myofibroblast phenotype and oncofetal variants of fibronectin.

Authors:  A Berndt; H Kosmehl; U Mandel; U Gabler; X Luo; D Celeda; L Zardi; D Katenkamp
Journal:  Histochem J       Date:  1995-12

Review 6.  Case report: primary CD30 (Ki-1)-positive anaplastic large cell lymphoma of the duodenum.

Authors:  I Yoshikawa; I Murata; Y Tanaka; K Kanagawa; A Tabaru; H Itoh; M Otsuki
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

Review 7.  Primary platelet-derived growth factor-producing, spindle-shaped diffuse large B-cell lymphoma of the skull: a case report and literature review.

Authors:  Kei-Ji Sugimoto; Asami Shimada; Kunimoto Ichikawa; Mutsumi Wakabayashi; Yasunobu Sekiguchi; Hiroshi Izumi; Yasunori Ota; Norio Komatsu; Masaaki Noguchi
Journal:  Int J Clin Exp Pathol       Date:  2014-06-15

8.  Childhood non-Hodgkin lymphomas in the United Kingdom: findings from the UK Children's Cancer Study Group.

Authors:  D Wright; P McKeever; R Carter
Journal:  J Clin Pathol       Date:  1997-02       Impact factor: 3.411

9.  Rapidly growing primary gastric CD30 (Ki-1)-positive anaplastic large cell lymphoma.

Authors:  S Nakamura; K Aoyagi; A Ohkuni; Y Kimura; M Tsuneyoshi; M Fujishima
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

10.  Cytokeratin positive T cell malignant lymphoma.

Authors:  W G McCluggage; M el-Agnaff; M D O'Hara
Journal:  J Clin Pathol       Date:  1998-05       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.